Health system managers demand evidence with real-life data to minimize their risks due to the informational asymmetry and uncertainties found in the sector. The need to manage costs through better alignment with the effectiveness of prescribed and incorporated technologies has generated an increase in experimentation and collaborations between manufacturers and payers in recent years and negotiations based on a risk-sharing agreement have come to meet this demand.

As a result of these negotiations, the final price of health technologies is conditioned by metrics related to effectiveness and clinical quality in order to bring sustainability to the system through evidence and change in decision-making by physicians and managers.

MAPESolutions is an international reference in terms of the strategic development and operationalization of these contracts with audit support capability, Health Technology Assessment and legal / risk assessment. In recent years, we have developed a digital platform in order to collect, monitor and analyze indicators, whether clinical or financial, operating shared risk contracts between the Life Science industry, payers and healthcare service providers.